MXPA01011287A - Derivados de ciclotiocarbamato como moduladores de receptor de progesterona. - Google Patents

Derivados de ciclotiocarbamato como moduladores de receptor de progesterona.

Info

Publication number
MXPA01011287A
MXPA01011287A MXPA01011287A MXPA01011287A MXPA01011287A MX PA01011287 A MXPA01011287 A MX PA01011287A MX PA01011287 A MXPA01011287 A MX PA01011287A MX PA01011287 A MXPA01011287 A MX PA01011287A MX PA01011287 A MXPA01011287 A MX PA01011287A
Authority
MX
Mexico
Prior art keywords
alkyl
optionally substituted
aryl
ring
groups
Prior art date
Application number
MXPA01011287A
Other languages
English (en)
Spanish (es)
Inventor
P Edwards James
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/552,354 external-priority patent/US6436929B1/en
Application filed by American Home Prod filed Critical American Home Prod
Publication of MXPA01011287A publication Critical patent/MXPA01011287A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/18—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Detergent Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MXPA01011287A 1999-05-04 2000-05-01 Derivados de ciclotiocarbamato como moduladores de receptor de progesterona. MXPA01011287A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18301399P 1999-05-04 1999-05-04
US09/552,354 US6436929B1 (en) 1999-05-04 2000-04-19 Cyclothiocarbamate derivatives as progesterone receptor modulators
PCT/US2000/011749 WO2000066570A1 (en) 1999-05-04 2000-05-01 Cyclothiocarbamate derivatives as progesterone receptor modulators

Publications (1)

Publication Number Publication Date
MXPA01011287A true MXPA01011287A (es) 2003-07-14

Family

ID=26878649

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01011287A MXPA01011287A (es) 1999-05-04 2000-05-01 Derivados de ciclotiocarbamato como moduladores de receptor de progesterona.

Country Status (24)

Country Link
EP (1) EP1175411B1 (enExample)
JP (2) JP4958338B2 (enExample)
KR (1) KR100732692B1 (enExample)
CN (1) CN1131856C (enExample)
AT (1) ATE386729T1 (enExample)
AU (1) AU766801B2 (enExample)
BG (1) BG65277B1 (enExample)
BR (1) BR0010214A (enExample)
CA (1) CA2371712C (enExample)
CZ (1) CZ20013952A3 (enExample)
DE (1) DE60038108T2 (enExample)
DK (1) DK1175411T3 (enExample)
EA (1) EA004511B1 (enExample)
ES (1) ES2301482T3 (enExample)
GE (1) GEP20043181B (enExample)
HU (1) HUP0203332A3 (enExample)
IL (1) IL146298A0 (enExample)
MX (1) MXPA01011287A (enExample)
NO (1) NO321370B1 (enExample)
NZ (1) NZ515353A (enExample)
PL (1) PL351083A1 (enExample)
SG (1) SG120970A1 (enExample)
SK (1) SK15922001A3 (enExample)
TR (1) TR200103285T2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1131856C (zh) * 1999-05-04 2003-12-24 美国家庭用品有限公司 作为黄体酮受体调节剂的环硫代氨基甲酸酯衍生物
US6407101B1 (en) * 1999-05-04 2002-06-18 American Home Products Corporation Cyanopyrroles
CA2561313C (en) * 2004-04-08 2012-12-04 Wyeth Methods for minimizing thioamide impurities
BRPI0509209A (pt) * 2004-04-08 2007-08-28 Wyeth Corp composto, métodos para contracepção, terapia de reposição hormonal, tratamento ou prevenção de doença neoplásica dependente de hormÈnios; tratamento de sangramento disfuncional ou da sìndrome de ovários policìsticos; sincronização do estro; tratamento da acne ou tratamento do hirsutismo, e para preparação do composto, composição farmacêutica, kit farmacêutico, e, uso de um composto
ATE396189T1 (de) * 2004-04-27 2008-06-15 Wyeth Corp Cyanopyrrolhaltige cyclische carbamat- und thiocarbamatbiaryle und verfahren zu deren herstellung
AU2005237520B2 (en) 2004-04-27 2012-01-19 Wyeth Purification of progesterone receptor modulators
JP5288796B2 (ja) * 2004-07-07 2013-09-11 ワイス・エルエルシー 周期的プロゲスチンレジメン及びキット
WO2006020712A1 (en) * 2004-08-13 2006-02-23 Wyeth Tanaproget derivatives, metabolites, and uses thereof
PL1896034T3 (pl) * 2005-04-28 2010-07-30 Wyeth Llc Mikronizowane kompozycje tanaprogetu i sposoby ich wytwarzania
SI1877059T1 (sl) 2005-04-28 2010-07-30 Wyeth Llc Mikroniziran tanaproget in sestavki, ki ga vsebujejo
BRPI0610438A2 (pt) 2005-04-28 2012-10-23 Wyeth Corp composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição
MX2007013469A (es) * 2005-04-28 2008-01-22 Wyeth Corp Forma ii polimorfa de tanaproget.
CN101184738B (zh) * 2005-04-28 2012-05-23 惠氏公司 纯化型的tanaproget
US20060280800A1 (en) * 2005-06-09 2006-12-14 Wyeth Tanaproget compositions containing ethinyl estradiol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0510235A1 (en) * 1991-04-26 1992-10-28 Dong-A Pharm. Co., Ltd. Novel benzoxazine or benzothiazine derivatives and process for the preparation of the same
JPH0510235A (ja) * 1991-07-05 1993-01-19 Nippondenso Co Ltd 内燃機関の点火時期制御装置
AU1694295A (en) * 1994-01-28 1995-08-15 Merck & Co., Inc. Benzoxazinones as inhibitors of hiv reverse transcriptase
NZ300739A (en) * 1994-12-22 2000-05-26 Ligand Pharm Inc Steroid receptor modulator compounds
US5688808A (en) * 1994-12-22 1997-11-18 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
EP0929533B1 (en) * 1996-10-02 2003-09-03 Bristol-Myers Squibb Pharma Company 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
CN1131856C (zh) * 1999-05-04 2003-12-24 美国家庭用品有限公司 作为黄体酮受体调节剂的环硫代氨基甲酸酯衍生物
SI1877059T1 (sl) * 2005-04-28 2010-07-30 Wyeth Llc Mikroniziran tanaproget in sestavki, ki ga vsebujejo
US20060280800A1 (en) * 2005-06-09 2006-12-14 Wyeth Tanaproget compositions containing ethinyl estradiol

Also Published As

Publication number Publication date
KR20020000170A (ko) 2002-01-04
NZ515353A (en) 2004-03-26
CA2371712A1 (en) 2000-11-09
CA2371712C (en) 2009-12-22
CN1131856C (zh) 2003-12-24
AU766801B2 (en) 2003-10-23
KR100732692B1 (ko) 2007-06-27
BG65277B1 (bg) 2007-11-30
PL351083A1 (en) 2003-03-10
NO20015381L (no) 2002-01-03
EA200101181A1 (ru) 2002-04-25
NO321370B1 (no) 2006-05-02
EP1175411B1 (en) 2008-02-20
JP2002543192A (ja) 2002-12-17
DK1175411T3 (da) 2008-06-09
SG120970A1 (en) 2006-04-26
SK15922001A3 (sk) 2002-09-10
CN1349516A (zh) 2002-05-15
GEP20043181B (en) 2004-02-25
ATE386729T1 (de) 2008-03-15
JP2012087129A (ja) 2012-05-10
HUP0203332A2 (hu) 2003-01-28
TR200103285T2 (tr) 2002-02-21
DE60038108D1 (de) 2008-04-03
CZ20013952A3 (cs) 2002-05-15
NO20015381D0 (no) 2001-11-02
HUP0203332A3 (en) 2004-12-28
IL146298A0 (en) 2002-07-25
BG106080A (en) 2002-05-31
JP5523430B2 (ja) 2014-06-18
EP1175411A1 (en) 2002-01-30
BR0010214A (pt) 2002-02-13
EA004511B1 (ru) 2004-04-29
DE60038108T2 (de) 2009-02-12
ES2301482T3 (es) 2008-07-01
JP4958338B2 (ja) 2012-06-20
AU4811900A (en) 2000-11-17

Similar Documents

Publication Publication Date Title
UA72917C2 (en) Cyclic carbamates derivatives, pharmaceutical composition containing said derivatives of cyclic carbamates and active ingredients as modulators of the progesterone receptor
IL146298A0 (en) Cyclothiocarbamate derivatives as progesterone receptor modulators
WO2000066564A8 (en) Benzimidazolones and analogues and their use as progesterone receptor ligands
BR0109855A (pt) Derivados de 8-isoquinolinxantina e 8-quinolixantina como inibidores de pde 5
HUP0300641A2 (hu) Triazaspiro[5.5]undekán-származékok és hatóanyagként ezeket tartalmazó gyógyszerkészítmények
HUP9801688A2 (hu) Acetamidszármazékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
NZ324007A (en) Quinazoline derivatives susbtituted by a phenyl and medicaments
ATE204269T1 (de) Substituierte biphenyl- oder phenylpyridinderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
AR007440A1 (es) Compuestos triciclos fenilamino sustituidos y composiciones farmaceuticas de los mismos.
AR035235A1 (es) Derivados heterocicliloxi-,-tioxi- y -aminobenzazol como ligandos de 5-hidroxitriptamina-6, un procedimiento para su preparacion, composicion farmaceutica, y el uso de dichos derivados para la manufactura de un medicamento
EA200600811A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ ТЕТРАГИДРОСПИРО {ПИПЕРИДИН-2,7'-ПИРРОЛО [3,2-b]ПИРИДИНА} И НОВЫЕ ПРОИЗВОДНЫЕ ИНДОЛА, ПРИМЕНЕНИЕ ДЛЯ ЛЕЧЕНИЯ РАССТРОЙСТВ, СВЯЗАННЫХ С 5-HT-РЕЦЕПТОРОМ
BR0014901A (pt) Derivados de trifenil-alquenos e seu uso como moduladores de receptores seletivos de estrogênios
ID22636A (id) Zat-zat terapeutik
NO20045369L (no) Nye, substituerte sulfamatanticonvulsivaderivater
NO20004778L (no) Amidderivater og nociceptin antagonister
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
HUP0204587A2 (en) 6-position substituted indoline, production and use thereof as a medicament
HUP9901096A2 (hu) Indolszármazékok, előállításuk és alkalmazásuk, a vegyületeket tartalmazó gyógyászati készítmények
EE03872B1 (et) Arüülglütsiinamiidi derivaadid, meetod nende valmistamiseks ja neid ühendeid sisaldavad farmatseutilised preparaadid
ZA988668B (en) Novel 5-membered ring heterocycles their preparation their use and pharmaceutical preparations comprising them
HUP9700595A1 (hu) Fluor-alkil- és fluor-alkoxicsoporttal helyettesített heterociklikus bradikinin-antagonisták, eljárás ezek előállítására, valamint ezek alkalmazása
NZ336189A (en) Diaza-spiro[3,5]nonane derivatives and use in treatment of diseases related to the orphanin receptor
TW334425B (en) Annelated dihydropyridines for preparing pharmaceutical preparations
NZ515355A (en) Cyclocarbamate derivatives as progesterone receptor modulators
JPS6470412A (en) Medicinal composition

Legal Events

Date Code Title Description
GB Transfer or rights
HC Change of company name or juridical status
GB Transfer or rights
FG Grant or registration